1.Analysis of components absorbed into blood and brain of Lithocarpus litseifolius leaves
Huan LIU ; Zirong YI ; Ting HUANG ; Xiuhong LIU ; Yunyao YE ; Yuming MA ; Mengqi HU ; Nan ZHANG ; Wenhao YANG ; Yang LIU ; Guopeng WANG
China Pharmacy 2026;37(7):889-894
OBJECTIVE To analyze the prototype components absorbed into blood and brain of Lithocarpus litseifolius leaves, so as to provide a reference for clarifying the pharmacological material basis of its prevention and treatment of central nervous system dis eases. METHODS The ethanol extract of L. litseifolius leaves, as well as the gastric lavage fluid and perfusion solution were prepared. Using rats as subjects, plasma samples of intestinal wall metabolism, intestinal flora metabolism and hepatic metabolism were prepared via in situ intestinal perfusion and closed intestinal loop method; while comprehensive metabolic plasma samples, brain tissue samples, and cerebrospinal fluid samples were collected after intragastric administration. UPLC-HRMS technology was utilized to analyze and identify chemical components and prototype components absorbed into blood and brain of L. litseifolius leaves. RESULTS A total of 66 chemical constituents were identified in L. litseifolius leaves, primarily consisting of flavonoids, organic acids, and others. A total of 16, 13, 11, and 5 prototype components were identified in intestinal wall metabolism, intestinal flora metabolism, hepatic metabolism, and comprehensive metabolic plasma samples, respectively. Additionally, 4 prototype components were detected in brain tissue and 9 in cerebrospinal fluid. Phloridzin, trilobatin, phloretin-2- O -malonyl hexoside, and phloretin were identified as common components across all sample types. CONCLUSIONS Prototype components absorbed into blood and brain of L. litseifolius leaves, such as phloridzin, trilobatin, phloretin, and other components may serve as the pharmacological material basis for their therapeutic effects on central nervous system diseases.
2.Efficacy of 3D-nnU-Net model of CT virtual monoenergetic images,non-linear blending images and mixed-energy images for automatically segmenting advanced gastric cancer
Bowen LIU ; Xiaoxiao WANG ; Chao LU ; Zhixuan WANG ; Jiulou ZHANG ; Zehui WANG ; Siyuan LU ; Xiaoyue JIANG ; Mingyao QI ; Donggang PAN ; Xiuhong SHAN
Chinese Journal of Medical Imaging Technology 2025;41(5):753-758
Objective To compare the segmenting efficacy of automatic segmentation models for advanced gastric cancer(AGC)on CT virtual monoenergetic images(VMI),non-linear blending images(NLBI)and mixed-energy images(MEI)based on 3D-nnU-Net.Methods Totally 216 cases of AGC were retrospectively enrolled,among them 185 cases were used to construct,train and validate models and divided into training set(n=154)and test set(n=31)at the ratio of 5∶1,while the other 31 cases were used as validation set to evaluate the generalization of the models.The 70 keV energy level VMI(VMI70 keV),NLBI and MEI were reconstructed with whole-abdominal dual-energy mode venous CT,and automatic segmentation models of AGC,including VMI70 keV,NLBI and MEI models were constructed using 3D-nnU-Net,respectively.Taken manually segmented results as golden standards,the efficacy of each model for segmenting all lesions and T2 stage lesions in test set and validation set were evaluated using Dice similarity coefficient(DSC),intersection over union(IoU)and average symmetric surface distance(ASSD).Results For all lesions in test and validation sets,DSC of 3 models were all>0.80.DSC and IoU of VMI70 keV and NLBI models were both higher,while their ASSD was lower than those of MEI model(all P<0.05).For T2 stage AGC in both test set and validation set(each n=5),DSC of MEI model was lower than that of VMI70 keV and NLBI models(both P<0.05),while IoU of MEI model was lower than that of VMI70 keV model(P<0.05),and its ASSD was higher than that of NLBI model(P<0.05).Conclusion All 3D-nnU-Net-based VMI70 keV,NLBI and MEI models could effectively segment AGC on dual-energy CT images,and the segmentation efficacy of the former two were better.
3.Current status and influencing factors of self-care contributions in family caregivers of elderly stroke patients
Ting WANG ; XiuHong WANG ; MingYan QING ; JiangLan WANG
Modern Clinical Nursing 2025;24(5):18-24
Objective To investigate the current status of self-care contributions of family caregivers of elderly stroke patients and analyse the influencing factors.Methods Using convenience sampling method,170 family caregivers of elderly stroke patients hospitalised in the Departments of Neurology of two Tier-ⅢA hospitals in Guiyang between June and October 2023 were selected.Data were collected using general information questionnaires,the mutuality scale(MS),stroke knowledge questionnaire,social support rating scale(SSRS)and the self-care contribution assessment scale for caregivers of elderly stroke patients.Multiple linear regression was used to identify the factors that influenced self-care contributions.Results The score of self-care contribution of family caregivers was 40.97±15.04,including 15.24±6.94 for self-care maintenance,9.44±4.97 for self-care monitoring and 16.30±5.18 for self-care management.Multiple linear regression analysis showed that self-care contributions were significantly influenced(P<0.05)by the duration of care of family caregivers,knowledge of stroke,mutuality and the social support,toally accounting for 43.1%of the variation.Conclusion Family caregivers of elderly stroke patients show low self-care contributions.Medical staff should offer additional support to family caregivers who have a shorter caregiving time.Improvement of mutuality,knowledge of stroke and social support can improve caregivers'self-care contributions.
4.Analysis of single-center clinical data of juvenile dermatomyositis complicated with interstitial lung disease
Lingling GENG ; Yue PENG ; Li WANG ; Xiuhong XUE ; Xinran WEN ; Duomei SHI ; Xiaoqing LI
Chinese Pediatric Emergency Medicine 2025;32(10):764-768
Objective:To summarize the clinical data of single-center juvenile dermatomyositis(JDM)complicated with interstitial lung disease(ILD),and provide experience for pediatricians.Methods:Data of 61 children with JDM who were admitted to Children's Hospital affiliated to Xi'an Jiaotong University from January 2016 to May 2023 were collected. General data,clinical symptoms,chest high-resolution CT,laboratory examination and myositis antibody spectrum of the children were recorded.Results:Among the 61 children with JDM,there were 30 cases(13 males and 17 females)without ILD. The age of onset was 5.96(3.50,8.92)years and the course of disease was(11.79±20.00)months. There were 31 cases with ILD(14 males and 17 females),the age of onset was 7.42(4.50,10.08)years,and the duration of ILD was(5.47±8.09)months. There was statistical difference in the course of disease between the two groups( P<0.05),but no statistical difference in gender and age between the two groups( P>0.05). Among 61 children with JDM,there were statistical differences in fever between the two groups( P<0.05),but no statistical differences in heliotrope discoloration,gottron’s papules,calcinosis and myasthenia between the two groups( P>0.05). AST and FER showed statistical difference between the two groups( P<0.05),while CK,LDH,CK-MB,ESR,C3 and C4 showed no statistical difference( P>0.05). All 61 cases of children were tested for myositis antibody spectrum,and there was statistical difference in anti-MDA5 antibody between the two groups( P<0.05),but no statistical difference in the rest( P>0.05). There were statistical differences between the two groups in the treatment of methotrexate,hydroxychloroquine and cyclophosphamide( P<0.05). A total of 11 cases(36.67%)in the without ILD group were treated with biologics(8 adalimumab,2 infliximab and 1 tofacitinib),and 23 cases(74.19%)in the ILD group were treated with biologics(11 adalimumab,9 tofaciib,2 infliximab and 1 tocilizumab). All 61 cases with JDM were followed up. Among the 30 children without ILD,1 case was lost to follow-up 2 months after treatment,and the rest were treated effectively without death. Among the 31 children with ILD,3 cases died of severe pulmonary infection with multidrug-resistant bacteria during treatment,of which 1 case was positive for anti-MDA5 antibody and 2 cases were negative for myositis specific antibody. Conclusion:JDM is more likely to be complicated with ILD,fever is more likely to occur in ILD group,and children with positive anti-MDA5 antibody are more likely to occur ILD. Biologic agents such as adalimumab and tofacitinib are effective in combination therapy. In the course of treatment,multi-drug resistant bacteria infection should be guarded against to reduce mortality.
5.Textual analysis of provincial policy on nursing assistant training and management in China
Aihong MING ; Xiuhong LONG ; Zhijin LIANG ; Li LI ; Fengmin LI ; Sihui LIN ; Yunfan YANG ; Zhihui WANG ; Tian FENG
Chinese Journal of Nursing 2025;60(8):960-967
Objective To analyze the deployment of policy instruments and the distribution of stakeholder engagement in provincial policies on nursing assistant training and management.Methods The relevant policy texts on nursing assistant training and management were systematically searched and collected from the official websites of provincial governments and their direct departments,CNKI,and the PKU Law Database.A two-dimensional framework of policy instruments-stakeholder was constructed,and the content analysis was used to classify,encode and quantify policy clauses.Results The study encompassed 20 provincial-level nursing assistant training and management policies,yielding a total of 359 codes.Within the policy instruments dimension,environmental,supply,and demand instruments constituted 66.30%,28.97%,and 4.74%,respectively.In terms of stakeholders,the management-side accounted for 56.55%,providers and trainers for 18.11%each,partners for 5.01%,and demand-side for 2.23%.Both management-side and trainers engaged with 3 policy instruments,providers with 2,and partners and demand-side with one each.Conclusion In the provincial nursing assistant training and management policies,there are differences in the deployment of policy instruments,and the distribution of stakeholders is uneven.Managers should pay attention to publicity guidance and platform construction,improve incentive mechanisms and training programs,and innovate cooperation models with stakeholders,as well as strengthen communication and exchange.
6.Efficacy of 3D-nnU-Net model of CT virtual monoenergetic images,non-linear blending images and mixed-energy images for automatically segmenting advanced gastric cancer
Bowen LIU ; Xiaoxiao WANG ; Chao LU ; Zhixuan WANG ; Jiulou ZHANG ; Zehui WANG ; Siyuan LU ; Xiaoyue JIANG ; Mingyao QI ; Donggang PAN ; Xiuhong SHAN
Chinese Journal of Medical Imaging Technology 2025;41(5):753-758
Objective To compare the segmenting efficacy of automatic segmentation models for advanced gastric cancer(AGC)on CT virtual monoenergetic images(VMI),non-linear blending images(NLBI)and mixed-energy images(MEI)based on 3D-nnU-Net.Methods Totally 216 cases of AGC were retrospectively enrolled,among them 185 cases were used to construct,train and validate models and divided into training set(n=154)and test set(n=31)at the ratio of 5∶1,while the other 31 cases were used as validation set to evaluate the generalization of the models.The 70 keV energy level VMI(VMI70 keV),NLBI and MEI were reconstructed with whole-abdominal dual-energy mode venous CT,and automatic segmentation models of AGC,including VMI70 keV,NLBI and MEI models were constructed using 3D-nnU-Net,respectively.Taken manually segmented results as golden standards,the efficacy of each model for segmenting all lesions and T2 stage lesions in test set and validation set were evaluated using Dice similarity coefficient(DSC),intersection over union(IoU)and average symmetric surface distance(ASSD).Results For all lesions in test and validation sets,DSC of 3 models were all>0.80.DSC and IoU of VMI70 keV and NLBI models were both higher,while their ASSD was lower than those of MEI model(all P<0.05).For T2 stage AGC in both test set and validation set(each n=5),DSC of MEI model was lower than that of VMI70 keV and NLBI models(both P<0.05),while IoU of MEI model was lower than that of VMI70 keV model(P<0.05),and its ASSD was higher than that of NLBI model(P<0.05).Conclusion All 3D-nnU-Net-based VMI70 keV,NLBI and MEI models could effectively segment AGC on dual-energy CT images,and the segmentation efficacy of the former two were better.
7.Selective fetus reduction in a case of combined intrauterine and cesarean scar pregnancy: a case report
Shujia WANG ; Jie LI ; Sien MO ; Zhengxuan ZHANG ; Xiuhong AN ; Zhong LIN
Chinese Journal of Reproduction and Contraception 2025;45(9):945-947
To evaluate the clinical efficacy of selective fetal reduction in the first trimester for the treatment of intrauterine pregnancy combined with cesarean scar pregnancy (CI-CSP), this article reports a 41-year-old pregnant woman diagnosed with CI-CSP after assisted reproductive technology. At 6 + weeks of gestation, mechanical fetal reduction surgery was performed under ultrasound guidance to eliminate the fetus at the scar site, and the fetal reduction was successful. The pregnancy lasted until 38 weeks of gestation. A healthy male infant was delivered by cesarean section. This case suggests that selective fetal reduction surgery can be a feasible option to preserve intrauterine pregnancy and reduce the risk of CI-CSP, but the indications and perioperative management need to be strictly controlled.
8.Analysis of single-center clinical data of juvenile dermatomyositis complicated with interstitial lung disease
Lingling GENG ; Yue PENG ; Li WANG ; Xiuhong XUE ; Xinran WEN ; Duomei SHI ; Xiaoqing LI
Chinese Pediatric Emergency Medicine 2025;32(10):764-768
Objective:To summarize the clinical data of single-center juvenile dermatomyositis(JDM)complicated with interstitial lung disease(ILD),and provide experience for pediatricians.Methods:Data of 61 children with JDM who were admitted to Children's Hospital affiliated to Xi'an Jiaotong University from January 2016 to May 2023 were collected. General data,clinical symptoms,chest high-resolution CT,laboratory examination and myositis antibody spectrum of the children were recorded.Results:Among the 61 children with JDM,there were 30 cases(13 males and 17 females)without ILD. The age of onset was 5.96(3.50,8.92)years and the course of disease was(11.79±20.00)months. There were 31 cases with ILD(14 males and 17 females),the age of onset was 7.42(4.50,10.08)years,and the duration of ILD was(5.47±8.09)months. There was statistical difference in the course of disease between the two groups( P<0.05),but no statistical difference in gender and age between the two groups( P>0.05). Among 61 children with JDM,there were statistical differences in fever between the two groups( P<0.05),but no statistical differences in heliotrope discoloration,gottron’s papules,calcinosis and myasthenia between the two groups( P>0.05). AST and FER showed statistical difference between the two groups( P<0.05),while CK,LDH,CK-MB,ESR,C3 and C4 showed no statistical difference( P>0.05). All 61 cases of children were tested for myositis antibody spectrum,and there was statistical difference in anti-MDA5 antibody between the two groups( P<0.05),but no statistical difference in the rest( P>0.05). There were statistical differences between the two groups in the treatment of methotrexate,hydroxychloroquine and cyclophosphamide( P<0.05). A total of 11 cases(36.67%)in the without ILD group were treated with biologics(8 adalimumab,2 infliximab and 1 tofacitinib),and 23 cases(74.19%)in the ILD group were treated with biologics(11 adalimumab,9 tofaciib,2 infliximab and 1 tocilizumab). All 61 cases with JDM were followed up. Among the 30 children without ILD,1 case was lost to follow-up 2 months after treatment,and the rest were treated effectively without death. Among the 31 children with ILD,3 cases died of severe pulmonary infection with multidrug-resistant bacteria during treatment,of which 1 case was positive for anti-MDA5 antibody and 2 cases were negative for myositis specific antibody. Conclusion:JDM is more likely to be complicated with ILD,fever is more likely to occur in ILD group,and children with positive anti-MDA5 antibody are more likely to occur ILD. Biologic agents such as adalimumab and tofacitinib are effective in combination therapy. In the course of treatment,multi-drug resistant bacteria infection should be guarded against to reduce mortality.
9.Research Progress on the Mechanism of Intestinal Administration of Chinese Medicine in Treating Ulcerative Colitis
Geng YU ; Xu WANG ; Lin DING ; Tingting LIU ; Yongqi ZHAO ; Xia WU ; Faming ZHANG ; Xiuhong WU
Journal of Nanjing University of Traditional Chinese Medicine 2025;41(10):1300-1311
Chinese medicine intestinal administration(CMIA)can avoid the degradation of drugs in gastric acid,bypass the first-pass effect of the liver,and deliver drugs directly to the lesion site.This approach increases local drug concentration,reduces drug dosage,and enhances bioavailability.This study systematically introduces the advantages,drug dosage forms,and whole-colon deliv-ery technologies of CMIA for treating UC,and reviews its mechanisms of action,including repairing intestinal epithelial layer and mu-cous layer,regulating the intestinal microbiota,improving immune function,and promoting local blood circulation.It also analyzes the current progress and limitations of research,aiming to provide a more solid theoretical basis for the treatment of UC with Chinese medi-cine and to offer references for the development of UC therapeutic drugs and administration methods.
10.Therapeutic efficacy and influencing factors of ceftazidime/avibactam in lung transplant recipients with pulmonary infection caused by carbapenem-resistant Gram-negative bacilli
Zhigang QI ; Chenglong LIANG ; Yating GUO ; Xiaoshan LI ; Hongmei WANG ; Lingzhi SHI ; Bo WU ; Jingyu CHEN ; Xiuhong ZHANG
Chinese Journal of Infection Control 2025;24(7):940-946
Objective To investigate the clinical application of ceftazidime/avibactam(CAZ/AVI)in lung trans-plant recipients with pulmonary infection caused by carbapenem-resistant Gram-negative bacilli(CRGNB),and ana-lyze the factors affecting the prognosis.Methods Lung transplant recipients who had CRGNB pulmonary infection and were treated with CAZ/AVI were included in the analysis.Based on 14-day clinical response,14-day microbial response,and 30-day survival status,the recipients were divided into a clinical response group and a clinical failure group,a microbial response group and a microbial failure group,as well as a survival group and a death group,re-spectively.Univariate analysis was conducted on various data from the two groups.Factors affecting therapeutic ef-ficacy and survival were included in a binary logistic regression model.Independent risk factors for CAZ/AVI anti-infective efficacy and all-cause mortality outcomes were analyzed.Results A total of 43 recipients were included.After 14-day anti-infective treatment,32 recipients(74.42%)achieved clinical response,and 30 recipients(69.77%)achieved microbial response.34 recipients(79.07%)survived 30 days after CAZ/AVI treatment.The Charlson comorbidity index(CCI),proportion of renal dysfunction,and incidence of shock in recipients in the clini-cal response group were all lower than those in the clinical failure group(P<0.05),while the serum albumin(ALB)level was higher(P<0.05).The incidence of shock in recipients in the microbial response group was lower than that in the microbial failure group(P<0.05).CCI,proportion of renal dysfunction,and incidence of shock in recipients in the survival group were all lower than those in the death group(all P<0.05),while ALB level was higher during treatment period(P<0.05).Multivariate analysis of 14-day clinical response and 30-day survival showed that higher CCI was an independent risk factor affecting 14-day clinical response of recipients(OR=2.22,95%CI:1.07-4.63),while lower ALB levels(OR=0.72,95%CI:0.54-0.98)and higher CCI(OR=5.27,95%CI:1.18-23.58)were independent risk factors for 30-day all-cause mortality in recipients with pulmonary in-fection after lung transplant.Conclusion CAZ/AVI may be an effective drug for treating pulmonary infection caused by CRGNB in lung transplant recipients.Higher CCI is an independent risk factor for 14-day clinical failure in recipients after CAZ/AVI treatment.Lower ALB level and higher CCI are independent risk factors for increased 30-day mortality in recipients.

Result Analysis
Print
Save
E-mail